DarioHealth Corp. Warrant
DRIOW
DRIOW was delisted on the 4th of March, 2021.
3 hedge funds and large institutions have $2K invested in DarioHealth Corp. Warrant in 2018 Q4 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 2 reducing their positions, and closing their positions.
50% more funds holding
Funds holding: 2 → 3 (+1)
82% less capital invested
Capital invested by funds: $11K → $2K (-$9K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$6.15K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$1.16K |
| 2 |
BA
Bard Associates
Chicago,
Illinois
|
-$117 |
DRIOW Hedge Fund Activity: Q4 2018 in Review
3 of the 4,489 institutional investors tracked by Wall St. Rank reported a position in DarioHealth Corp. Warrant (DRIOW) for Q4 2018, worth a combined $2K — down 82% from $11K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new DRIOW positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 2 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $6.15K. The largest seller was UBS Group, cutting an estimated $1.16K.
- 3 institutional investors held DarioHealth Corp. Warrant (DRIOW) as of Q4 2018, up from 2 in Q3 2018.
- Funds reported $2K of DarioHealth Corp. Warrant stock for Q4 2018, down 82% quarter-over-quarter.
- 1 fund opened new DarioHealth Corp. Warrant positions in Q4 2018 and 0 closed out, a net change of +1 holder.
- The largest DarioHealth Corp. Warrant buyer in Q4 2018 was Susquehanna International Group, an estimated $6.15K added.
- The largest DarioHealth Corp. Warrant seller in Q4 2018 was UBS Group, an estimated $1.16K sold.
Based on aggregated 13F filings for Q4 2018.